Cathepsin B-like cysteine protease ApCathB negatively regulates cryo-injury tolerance in transgenic Arabidopsis and Agapanthus praecox

Plant Science ◽  
2021 ◽  
pp. 110928
Author(s):  
Guanqun Chen ◽  
Di Zhang ◽  
Jian Pan ◽  
Jianhua Yue ◽  
Xiaohui Shen
Aquaculture ◽  
2010 ◽  
Vol 310 (1-2) ◽  
pp. 38-42 ◽  
Author(s):  
Eleanor Cunningham ◽  
Elaine McCarthy ◽  
Lorraine Copley ◽  
Dave Jackson ◽  
David Johnson ◽  
...  

2005 ◽  
Vol 386 (9) ◽  
Author(s):  
Vivian Hook ◽  
Thomas Toneff ◽  
Matthew Bogyo ◽  
Doron Greenbaum ◽  
Katalin F. Medzihradszky ◽  
...  

AbstractThe regulated secretory pathway of neurons is the major source of extracellular Aβ that accumulates in Alzheimer's disease (AD). Extracellular Aβ secreted from that pathway is generated by β-secretase processing of amyloid precursor protein (APP). Previously, cysteine protease activity was demonstrated as the major β-secretase activity in regulated secretory vesicles of neuronal chromaffin cells. In this study, the representative cysteine protease activity in these secretory vesicles was purified and identified as cathepsin B by peptide sequencing. Immunoelectron microscopy demonstrated colocalization of cathepsin B with Aβ in these vesicles. The selective cathepsin B inhibitor, CA074, blocked the conversion of endogenous APP to Aβ in isolated regulated secretory vesicles. In chromaffin cells, CA074Me (a cell permeable form of CA074) reduced by about 50% the extracellular Aβ released by the regulated secretory pathway, but CA074Me had no effect on Aβ released by the constitutive pathway. Furthermore, CA074Me inhibited processing of APP into the COOH-terminal β-secretase-like cleavage product. These results provide evidence for cathepsin B as a candidate β-secretase in regulated secretory vesicles of neuronal chromaffin cells. These findings implicate cathepsin B as β-secretase in the regulated secretory pathway of brain neurons, suggesting that inhibitors of cathepsin B may be considered as therapeutic agents to reduce Aβ in AD.


PLoS ONE ◽  
2012 ◽  
Vol 7 (3) ◽  
pp. e31914 ◽  
Author(s):  
Anaïs Rieux ◽  
Simon Gras ◽  
Fabien Lecaille ◽  
Alisson Niepceron ◽  
Marilyn Katrib ◽  
...  

2012 ◽  
Vol 8 (4S_Part_16) ◽  
pp. P577-P577
Author(s):  
Mark Kindy ◽  
Jin Yu ◽  
Michael Pierschbacher ◽  
Nancy Sipes ◽  
Greg Hook

Author(s):  
Amos Olalekan Akinyemi ◽  
George Bueno Santana Pereira ◽  
Fillipe Vieira Rocha

: A member of cathepsin enzymes called Cathepsin B, is a cysteine-protease enzyme that plays significant roles in metalloproteinase regulation. Cathepsin B stands out amidst other members of cathepsin because of its role in both normal body physiology and pathophysiology. Being an anti-apoptotic and a pro-apoptotic agent, Cathepsin B has been reported to have deleterious effects, especially when its expression, activities, and distribution are outrageous. The over-expression of cathepsin B is traceable to dysregulation of one or more regulated steps involved in its synthesis. Consequently, the over-expression of cathepsin B contributes to the pathogenesis of different types of cancers – a global menace. Interestingly, the synthesis of this enzyme has been reported to be inhibited by several metal compounds, thus, curbing its involvement in carcinogenesis. In this review, the synthesis, structure, localization, and roles of cathepsin B in carcinogenesis were explored. Likewise, we also discussed the capacity of metallic compounds to inhibit this enzyme. Metals such as gold, ruthenium, palladium, Iridium, and Tellurium demonstrated remarkable activity toward cathepsin B of different modes. A relationship between cytotoxicity and inhibition constants was observed.


Sign in / Sign up

Export Citation Format

Share Document